Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Types of HIV tests news

Show

From To
bioLytical's INSTI HIV/Syphilis Multiplex Test Cleared for European Market

bioLytical Laboratories Inc., a leading manufacturer of rapid point-of-care diagnostic tests, announced today that its INSTI™ HIV/Syphilis Multiplex Test has been cleared for immediate market entry in the European Union through its' Notified Body. With this approval, the INSTI™ HIV/Syphilis Multiplex Test is available for simultaneous detection of Syphilis, HIV-1 and HIV-2 antibodies in as little as 60 seconds.

Published
16 February 2015
From
PR Newswire
Smartphone, Finger Prick, 15 Minutes, Diagnosis—Done!

A team of researchers, led by Samuel K. Sia, associate professor of biomedical engineering at Columbia Engineering, has developed a low-cost smartphone accessory that can perform a point-of-care test that simultaneously detects three infectious disease markers from a finger prick of blood in just 15 minutes.

Published
09 February 2015
From
Columbia University press release
FDA OKs Wider Use of Rapid Test That Better Detects Early HIV

The FDA has granted permission for more widespread use of a rapid test that can detect HIV earlier after infection than standard antibody tests. 

Published
12 December 2014
From
AIDSMeds
UNITAID invests to identify some of the 19 million HIV undetected

With an estimated 19 million people living with HIV globally unaware they have the virus, UNITAID is investing $23 million to accelerate access to simple self-tests in three high burden African countries over the next two years.

Published
02 December 2014
From
UNITAID
HIV self-test maker to raise £150,000

An Essex company which aims to be the first to bring a HIV self-test to the UK market is on track to raise £150,000 through a crowdfunding round.

Published
07 November 2014
From
Insider Media
CDC Revises HIV Testing Guidelines to Better ID Early Cases

The CDC has recommended a new HIV testing protocol for laboratories that will better identify acute cases of the virus.

Published
27 June 2014
From
AIDSMeds
Scaling up access to HIV testing through new technologies

What is HIV self-testing and what could it accomplish? This is the first question that a new UNAIDS/WHO technical update on self-testing for HIV addresses. The update aims to synthesize experiences, research and policies on HIV self-testing in order to inform stakeholders who are considering or already implementing such an approach.

Published
28 May 2014
From
UNAIDS
HIV testing: Home Sampling vs. Home Testing, a primer for users (and others)

Home testing and home sampling are not one and the same and it is important for potential users  and their providers to understand the key differences between the two.

Published
07 April 2014
From
Incidence 0
HIV Testing and Self-Testing: Answers to frequently asked questions

This document provides important information for people thinking about buying a self-test kit for HIV, or having an HIV test. UK law changed in April 2014 and self-test kits for HIV can now be sold in England, Scotland and Wales. At the moment no self-test kits for HIV have been CE marked for the UK or EU market, but this is expected to change in 2014/15.

Published
06 April 2014
From
Public Health England
MedMira Receives Approval To Market Reveal® Rapid HIV Test With New Features in Europe

MedMira Inc. (TSXV: MIR) has received approval to market an enriched version of its Reveal HIV test that simplifies the test procedure, enabling direct use of whole blood specimens – making the test even more convenient for point-of-care test users, especially in emergency situations when every second counts.

Published
13 March 2014
From
MedMira press release

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.